Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Mar;48(3):390–396. doi: 10.1136/gut.48.3.390

Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial

G Pomier-Layrargues 1, J Villeneuve 1, M Deschenes 1, B Bui 1, P Perreault 1, D Fenyves 1, B Willems 1, D Marleau 1, M Bilodeau 1, M Lafortune 1, M Dufresne 1
PMCID: PMC1760139  PMID: 11171831

Abstract

BACKGROUND AND AIMS—The transjugular intrahepatic portosystemic shunt (TIPS) is a new therapeutic modality for variceal bleeding. In this study we compared the two year survival and rebleeding rates in cirrhotic patients treated by either variceal band ligation or TIPS for variceal bleeding.
METHODS—Eighty cirrhotic patients (Pugh score 7-12) with variceal bleeding were randomly allocated to TIPS (n=41) or ligation (n=39), 24 hours after control of bleeding.
RESULTS—Mean follow up was 581 days in the ligation group and 678 days in the TIPS group. The two year survival rate was 57% in the TIPS group and 56% in the ligation group (NS); the incidence of variceal rebleeding after two years was 18% in the TIPS group and 66% in the ligation group (p<0.001). Uncontrolled rebleeding occurred in 11 patients in the ligation group (eight were rescued by emergency TIPS) but in none of the TIPS group. The incidence of encephalopathy at two years was 47% in the TIPS group and 44% in the ligation group (NS).
CONCLUSIONS—TIPS did not increase the two year survival rate compared with variceal band ligation after variceal bleeding in cirrhotic patients with moderate or severe liver failure. It significantly reduced the incidence of variceal rebleeding without increasing the rate of encephalopathy.


Keywords: portal hypertension; cirrhosis; variceal bleeding; transjugular intrahepatic portosystemic shunt; variceal band ligation

Full Text

The Full Text of this article is available as a PDF (150.4 KB).

Figure 1  .

Figure 1  

Open in a new tab

Cumulative proportion of patients surviving (Kaplan-Meier plot) in the ligation and transjugular intrahepatic portosystemic shunt (TIPS) groups.

Figure 2  .

Figure 2  

Open in a new tab

Cumulative proportion of patients free of variceal bleeding (Kaplan-Meier plot) in the ligation and transjugular intrahepatic portosystemic shunt (TIPS) groups.

Figure 3  .

Figure 3  

Open in a new tab

Cumulative proportion of patients free of hepatic encephalopathy (Kaplan-Meier plot) in the ligation and transjugular intrahepatic portosystemic shunt (TIPS) groups.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernard B., Lebrec D., Mathurin P., Opolon P., Poynard T. Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology. 1997 Jan;25(1):63–70. doi: 10.1053/jhep.1997.v25.pm0008985266. [DOI] [PubMed] [Google Scholar]
  2. Bilodeau M., Rioux L., Willems B., Pomier-Layrargues G. Transjugular intrahepatic portacaval stent shunt as a rescue treatment for life-threatening variceal bleeding in a cirrhotic patient with severe liver failure. Am J Gastroenterol. 1992 Mar;87(3):369–371. [PubMed] [Google Scholar]
  3. Cabrera J., Maynar M., Granados R., Gorriz E., Reyes R., Pulido-Duque J. M., Rodriguez SanRoman J. L., Guerra C., Kravetz D. Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage. Gastroenterology. 1996 Mar;110(3):832–839. doi: 10.1053/gast.1996.v110.pm8608893. [DOI] [PubMed] [Google Scholar]
  4. Cello J. P., Grendell J. H., Crass R. A., Trunkey D. D., Cobb E. E., Heilbron D. C. Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and variceal hemorrhage. N Engl J Med. 1984 Dec 20;311(25):1589–1594. doi: 10.1056/NEJM198412203112501. [DOI] [PubMed] [Google Scholar]
  5. Cello J. P., Ring E. J., Olcott E. W., Koch J., Gordon R., Sandhu J., Morgan D. R., Ostroff J. W., Rockey D. C., Bacchetti P. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med. 1997 Jun 1;126(11):858–865. doi: 10.7326/0003-4819-126-11-199706010-00002. [DOI] [PubMed] [Google Scholar]
  6. D'Amico G., Pagliaro L., Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995 Jul;22(1):332–354. doi: 10.1002/hep.1840220145. [DOI] [PubMed] [Google Scholar]
  7. García-Villarreal L., Martínez-Lagares F., Sierra A., Guevara C., Marrero J. M., Jiménez E., Monescillo A., Hernández-Cabrero T., Alonso J. M., Fuentes R. Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage. Hepatology. 1999 Jan;29(1):27–32. doi: 10.1002/hep.510290125. [DOI] [PubMed] [Google Scholar]
  8. Graham D. Y., Smith J. L. The course of patients after variceal hemorrhage. Gastroenterology. 1981 Apr;80(4):800–809. [PubMed] [Google Scholar]
  9. Haskal Z. J., Ring E. J., LaBerge J. M., Peltzer M. Y., Radosevich P. M., Doherty M. M., Gordon R. L. Role of parallel transjugular intrahepatic portosystemic shunts in patients with persistent portal hypertension. Radiology. 1992 Dec;185(3):813–817. doi: 10.1148/radiology.185.3.1438768. [DOI] [PubMed] [Google Scholar]
  10. Infante-Rivard C., Esnaola S., Villeneuve J. P. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatology. 1987 Jul-Aug;7(4):660–664. doi: 10.1002/hep.1840070408. [DOI] [PubMed] [Google Scholar]
  11. Infante-Rivard C., Esnaola S., Villeneuve J. P. Role of endoscopic variceal sclerotherapy in the long-term management of variceal bleeding: a meta-analysis. Gastroenterology. 1989 Apr;96(4):1087–1092. doi: 10.1016/0016-5085(89)91627-2. [DOI] [PubMed] [Google Scholar]
  12. Jalan R., Forrest E. H., Stanley A. J., Redhead D. N., Forbes J., Dillon J. F., MacGilchrist A. J., Finlayson N. D., Hayes P. C. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology. 1997 Nov;26(5):1115–1122. doi: 10.1002/hep.510260505. [DOI] [PubMed] [Google Scholar]
  13. Lafortune M., Martinet J. P., Denys A., Patriquin H., Dauzat M., Dufresne M. P., Colombato L., Pomier-Layrargues G. Short- and long-term hemodynamic effects of transjugular intrahepatic portosystemic shunts: a Doppler/manometric correlative study. AJR Am J Roentgenol. 1995 Apr;164(4):997–1002. doi: 10.2214/ajr.164.4.7726065. [DOI] [PubMed] [Google Scholar]
  14. Laine L., Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med. 1995 Aug 15;123(4):280–287. doi: 10.7326/0003-4819-123-4-199508150-00007. [DOI] [PubMed] [Google Scholar]
  15. Meddi P., Merli M., Lionetti R., De Santis A., Valeriano V., Masini A., Rossi P., Salvatori F., Salerno F., de Franchis R. Cost analysis for the prevention of variceal rebleeding: a comparison between transjugular intrahepatic portosystemic shunt and endoscopic sclerotherapy in a selected group of Italian cirrhotic patients. Hepatology. 1999 Apr;29(4):1074–1077. doi: 10.1002/hep.510290411. [DOI] [PubMed] [Google Scholar]
  16. Nazarian G. K., Ferral H., Bjarnason H., Castañeda-Zúiga W. R., Rank J. M., Bernadas C. A., Hunter D. W. Effect of transjugular intrahepatic portosystemic shunt on quality of life. AJR Am J Roentgenol. 1996 Oct;167(4):963–969. doi: 10.2214/ajr.167.4.8819395. [DOI] [PubMed] [Google Scholar]
  17. Orloff M. J., Bell R. H., Jr Long-term survival after emergency portacaval shunting for bleeding varices in patients with alcoholic cirrhosis. Am J Surg. 1986 Jan;151(1):176–183. doi: 10.1016/0002-9610(86)90029-2. [DOI] [PubMed] [Google Scholar]
  18. Papatheodoridis G. V., Goulis J., Leandro G., Patch D., Burroughs A. K. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis. Hepatology. 1999 Sep;30(3):612–622. doi: 10.1002/hep.510300316. [DOI] [PubMed] [Google Scholar]
  19. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
  21. Richter G. M., Noeldge G., Palmaz J. C., Roessle M., Slegerstetter V., Franke M., Gerok W., Wenz W., Farthman E. Transjugular intrahepatic portacaval stent shunt: preliminary clinical results. Radiology. 1990 Mar;174(3 Pt 2):1027–1030. doi: 10.1148/radiology.174.3.174-3-1027. [DOI] [PubMed] [Google Scholar]
  22. Rössle M., Haag K., Ochs A., Sellinger M., Nöldge G., Perarnau J. M., Berger E., Blum U., Gabelmann A., Hauenstein K. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med. 1994 Jan 20;330(3):165–171. doi: 10.1056/NEJM199401203300303. [DOI] [PubMed] [Google Scholar]
  23. Sanyal A. J., Freedman A. M., Luketic V. A., Purdum P. P., 3rd, Shiffman M. L., Cole P. E., Tisnado J., Simmons S. Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial. Ann Intern Med. 1997 Jun 1;126(11):849–857. doi: 10.7326/0003-4819-126-11-199706010-00001. [DOI] [PubMed] [Google Scholar]
  24. Sauer P., Theilmann L., Stremmel W., Benz C., Richter G. M., Stiehl A. Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding. Gastroenterology. 1997 Nov;113(5):1623–1631. doi: 10.1053/gast.1997.v113.pm9352865. [DOI] [PubMed] [Google Scholar]
  25. Villanueva C., Balanzó J., Novella M. T., Soriano G., Sáinz S., Torras X., Cussó X., Guarner C., Vilardell F. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med. 1996 Jun 20;334(25):1624–1629. doi: 10.1056/NEJM199606203342502. [DOI] [PubMed] [Google Scholar]
  26. Villeneuve J. P., Infante-Rivard C. Prevention of variceal rebleedling by propranolol: should it work? Does it work? Hepatology. 1987 Nov-Dec;7(6):1386–1388. doi: 10.1002/hep.1840070639. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES